Searched for
HETERO PHARMACY
Mankind Pharma set to roll out cheapest coronavirus drugThe full treatment of Molulife (brand name) is expected to cost ₹1,400, RC Juneja, chairman of Mankind Pharma, told ET. The brand is expect...- Companies race to make COVID antiviral drug molnupiravir available in pharmaciesDrug maker Cipla said it will soon make molnupiravir capsules available at all leading pharmacies and Covid treatment centers across the co...
- Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2,640"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...
- Hetero launches Favipiravir in India under the brand ‘Favivir’ to treat Covid-19This is the second drug developed by Hetero after Covifor, the generic version of Remdesivir injection to be administered intravenously in ...
- Hetero launches HumiraTM biosimilar in IndiaThe product will be marketed by Hetero Healthcare under the brand name ‘MaburaTM’ in India, the company said.
- Biocon shares gains on cancer drug launchA biosimilar is a near copy of an original complex biologic drug.
- We expect better EBITDA margins and higher profitability for FY17: Suneeta Reddy, MD, Apollo Hospitals"I think FY17 will be all about filling up beds, looking at higher occupancy and,therefore, better EBITDA margins so that our fixed costs w...
- No impact of Chennai floods on business: Suneeta Reddy, Apollo Hospitals"The other clusters too have done well except for one or two holiday-heavy weeks. During Diwali, there was understandably a dip in patients...
- CustomFurnish.com raises Rs 30 crore from Agnus CapitalCustomFurnish.com, a furniture portal has raised Rs 30 crore in a fresh round of funding from Bengaluru-based family office Agnus Capital.
- Boost for etailers like Flipkart, Amazon as Drugs Act to be tweaked to allow online salesThe government may consider changes to the Drugs and Cosmetics Act to permit online sale of medicines following representatins.
- Pharma firms like Pfizer and others replace medical representatives with new age executivesOf India’s more than six lakh medical representatives, specialists with management education qualifications account for a little over a six...
- Apollo Hospitals Q2 profit up 5% at Rs 91.50 croreThe company had posted a net profit of Rs 87 crore for the corresponding period of the previous fiscal, Apollo Hospitals Enterprise said in...
- Apollo Hospitals Enterprise to acquire HMSL's pharmacy stores for about Rs 146 croreApollo Hospitals Enterprise expects to leverage on it's proven track record of performance and operational capabilities to drive growth and...
- Twelve stocks in focus in Wednesday morning tradeIndian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to be in focus today.
- Apollo Hospitals in advanced talks to acquire Hetero PharmacyApollo operates 1,632 pharmacy stores across the country, while Hetero Pharmacy owns 250 outlets spread across Andhra Pradesh, Telangana an...
- New drug policy forces many pharmacies to shut shopThe new Drug Price Control Order (DPCO), which was notified on May 15, has made the prices of some 150 drugs fall steeply.
- Natco in talks with pharma retail chainsHyderabad-based drug company Natco Pharma, which launched its anti-HINI drug 'Natflu' in the national capital, said it is talking with vari...
- Govt gets into the act to combat fluThe health ministry is now building a bank of 6 million tablets of anti-viral tablets besides maintaining a stockpile of 10 million tablets.
- Retail sale of swine flu drug under lensThe Drug Controller General of India (DCGI) may soon crack the whip on those selling oseltamivir, the medicine to treat swine flu, in retai...
- Small firms all set to pep up pharma retailOrganised pharma retail, dominated by the likes of Apollo and Subiksha, is set for more action at the regional level.
Load More
